Literature DB >> 12509688

Critical review of unstable angina and non-ST elevation myocardial infarction.

P J Sheridan1, D C Crossman.   

Abstract

Within the coronary vasculature the progression of a stable atherosclerotic plaque into a vulnerable and ultimately unstable lesion leads to a cascade of events culminating in the clinical presentation of unstable angina or acute myocardial infarction. In recent years studies have provided new insights in to the pathology and natural history, stimulating advances in diagnosis, treatment, and management. The review discusses the progress made including the role of inflammation, cardiac biomarkers, antiplatelet therapy, and percutaneous intervention. Current issues of debate and future directions are also addressed.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12509688      PMCID: PMC1757938          DOI: 10.1136/pmj.78.926.717

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  75 in total

Review 1.  Low-molecular-weight heparins: an intriguing new twist with profound implications.

Authors:  E M Antman; R Handin
Journal:  Circulation       Date:  1998-07-28       Impact factor: 29.690

2.  Independent prognostic value of C-reactive protein and troponin I in patients with unstable angina or non-Q-wave myocardial infarction.

Authors:  R J de Winter; R Bholasingh; J G Lijmer; R W Koster; J P Gorgels; Y Schouten; F J Hoek; G T Sanders
Journal:  Cardiovasc Res       Date:  1999-04       Impact factor: 10.787

3.  Long-term effects of pravastatin on plasma concentration of C-reactive protein. The Cholesterol and Recurrent Events (CARE) Investigators.

Authors:  P M Ridker; N Rifai; M A Pfeffer; F Sacks; E Braunwald
Journal:  Circulation       Date:  1999-07-20       Impact factor: 29.690

4.  Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women.

Authors:  P M Ridker; J E Buring; J Shih; M Matias; C H Hennekens
Journal:  Circulation       Date:  1998-08-25       Impact factor: 29.690

5.  Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes.

Authors: 
Journal:  N Engl J Med       Date:  1998-08-13       Impact factor: 91.245

6.  Thermal heterogeneity within human atherosclerotic coronary arteries detected in vivo: A new method of detection by application of a special thermography catheter.

Authors:  C Stefanadis; L Diamantopoulos; C Vlachopoulos; E Tsiamis; J Dernellis; K Toutouzas; E Stefanadi; P Toutouzas
Journal:  Circulation       Date:  1999-04-20       Impact factor: 29.690

7.  Prognostic role of troponin T versus troponin I in unstable angina pectoris for cardiac events with meta-analysis comparing published studies.

Authors:  A G Olatidoye; A H Wu; Y J Feng; D Waters
Journal:  Am J Cardiol       Date:  1998-06-15       Impact factor: 2.778

8.  International, randomized, controlled trial of lamifiban (a platelet glycoprotein IIb/IIIa inhibitor), heparin, or both in unstable angina. The PARAGON Investigators. Platelet IIb/IIIa Antagonism for the Reduction of Acute coronary syndrome events in a Global Organization Network.

Authors: 
Journal:  Circulation       Date:  1998-06-23       Impact factor: 29.690

9.  Unstable coronary artery disease in post-menopausal women. Identifying patients with significant coronary artery disease by basic clinical parameters and exercise test. IRIS Study Group.

Authors:  K Säfström; N E Nielsen; A Björkholm; G Wiklund; E Swahn
Journal:  Eur Heart J       Date:  1998-06       Impact factor: 29.983

10.  Incremental prognostic value of serum levels of troponin T and C-reactive protein on admission in patients with unstable angina pectoris.

Authors:  A G Rebuzzi; G Quaranta; G Liuzzo; G Caligiuri; G A Lanza; J R Gallimore; R L Grillo; D Cianflone; L M Biasucci; A Maseri
Journal:  Am J Cardiol       Date:  1998-09-15       Impact factor: 2.778

View more
  6 in total

1.  Ratio Of Serum Asymmetric Dimethyl Arginine (ADMA)/ Nitric Oxide in Coronary Artery Disease patients.

Authors:  Rajni Rajendra Shivkar; Subodhini Anant Abhang
Journal:  J Clin Diagn Res       Date:  2014-08-20

2.  An initial exploration of subtraction electrocardiography to detect myocardial ischemia in the prehospital setting.

Authors:  Cornelia Cato Ter Haar; Ron J G Peters; Jan Bosch; Agnese Sbrollini; Sophia Gripenstedt; Rob Adams; Eduard Bleijenberg; Charles J H J Kirchhof; Reza Alizadeh Dehnavi; Laura Burattini; Robbert J de Winter; Peter W Macfarlane; Pieter G Postema; Sumche Man; Roderick W C Scherptong; Martin J Schalij; Arie C Maan; Cees A Swenne
Journal:  Ann Noninvasive Electrocardiol       Date:  2019-11-10       Impact factor: 1.468

3.  Compliance to secondary prevention strategies for coronary artery disease: a hospital-based cross-sectional survey from Ernakulam, South India.

Authors:  Remya Sudevan; Damodaran Vasudevan; Manu Raj; Rajesh Thachathodiyl; Maniyal Vijayakumar; Jabir Abdullakutty; Paul Thomas; Vijo George; Conrad Kabali
Journal:  BMJ Open       Date:  2020-10-10       Impact factor: 2.692

Review 4.  Cortisol on Circadian Rhythm and Its Effect on Cardiovascular System.

Authors:  Nor Amira Syahira Mohd Azmi; Norsham Juliana; Sahar Azmani; Nadia Mohd Effendy; Izuddin Fahmy Abu; Nur Islami Mohd Fahmi Teng; Srijit Das
Journal:  Int J Environ Res Public Health       Date:  2021-01-14       Impact factor: 3.390

5.  Compliance of Secondary Prevention Strategies in Coronary Artery Disease Patients with and without Diabetes Mellitus - A Cross-Sectional Analytical Survey from Kerala, India.

Authors:  Remya Sudevan; Manu Raj; Damodaran Madhavi Vasudevan; Chankramath Arun; Rajesh Thachathodiyl; Maniyal Vijayakumar; Jabir Abdullakutty; Paul Thomas; Vijo George; Conrad Kabali
Journal:  Indian J Endocrinol Metab       Date:  2021-09-08

6.  Hostility and physiological responses to laboratory stress in acute coronary syndrome patients.

Authors:  Lena Brydon; Philip C Strike; Mimi R Bhattacharyya; Daisy L Whitehead; Jean McEwan; Ian Zachary; Andrew Steptoe
Journal:  J Psychosom Res       Date:  2009-09-23       Impact factor: 3.006

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.